Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
2.320
-0.020 (-0.85%)
At close: Aug 14, 2026, 4:00 PM EDT
2.348
+0.028 (1.22%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Lexicon Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Lexicon Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $3.86. The average 1-year stock price forecast is 66.38% higher than the current stock price, while the lowest is $2.00 (-13.79%) and the highest is $6.00 (+158.62%).
Price Target: $3.86 (+66.38%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Lexicon Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $6 | Buy | Maintains | $6 | +158.62% | Aug 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $6 | Buy | Maintains | $6 | +158.62% | Aug 6, 2026 |
| Citi | Citi | Buy Maintains $2.3 → $3.1 | Buy | Maintains | $2.3 → $3.1 | +33.62% | May 11, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Hold Reiterates $1 | Hold | Reiterates | $1 | -56.90% | Mar 6, 2026 |
Financial Forecast
Revenue This Year
33.75M
from 49.80M
Decreased by -32.24%
Revenue Next Year
19.91M
from 33.75M
Decreased by -40.99%
EPS This Year
-0.17
from -0.14
EPS Next Year
-0.19
from -0.17
EPS and Forward PE are based on non-GAAP adjusted numbers.